Public health experts and researchers in Brazil breathed a sigh of relief on 25 October after Luiz Inácio […]
£8m initiative to support cancer discovery
Phase 2 data expected during 2027
Since its commercial launch in 2005, pregabalin has generated more than $50bn (£37bn; €44bn) in global revenue. Originally […]
Updated Date: Wed, 04 Nov 2026 00:00:00 EST
Event medicine provision is about to undergo a major shake up as the Care Quality Commission (CQC) begins […]
I agree with Chris Whitty that stepwise escalation in holding clinical risk benefits neither doctors nor patients.1 Instead, […]
Luiz Inácio Lula da Silva won Brazil’s presidential run-off, securing a fourth term after unprecedented popular mobilisation on […]
A new study found that energy drinks and stimulant supplements were linked to disproportionately frequent reports of serious […]
